Once-weekly treatment of tuberculosis with the diarylquinoline R207910: a real possibility.
Once-weekly treatment of tuberculosis with the diarylquinoline R207910: a real possibility.
复制标题
每周一次用二芳基喹啉 R207910 治疗结核病：确实有可能。
DOI：
10.1164/rccm.200808-1333ed
复制
发表时间：
2009
影响因子：
24.7
通讯作者：
Mitchison,DenisA
中科院分区：
文献类型：
--
作者：
Nuermberger,Eric;Mitchison,DenisA
2. Bremnes RM, Sirera R, Camps C. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 2005; 49: 1–12. 3. Ziegler A, Zangemeister-Wittke U, Stahel RA. Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 2002; 28: 255–271. 4. Gormally E, Caboux E, Vineis P, Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 2007; 635: 105–117. 5. Sozzi G, Conte D, Leon M, Ciricione R, Roz L, Ratcliffe C, Roz E, Cirenei N, Bellomi M, Pelosi G, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003; 21: 3902–3908. 6. Gormally E, Hainaut P, Caboux E, Airoldi L, Autrup H, Malaveille C, Dunning A, Garte S, Matullo G, Overvad K, et al. Amount of DNA in plasma and cancer risk: a prospective study. Int J Cancer2004; 111: 746–749. 7. Gormally E, Vineis P, Matullo G, Veglia F, Caboux E, Le Roux E, Peluso M, Garte S, Guarrera S, Munnia A, et al. TP53 and KRAS2 mutations in plasma DNA of healthy subjects and subsequent cancer occurrence: a prospective study. Cancer Res 2006; 66: 6871–6876. 8. Bach PB, Jett JR, Pastorino U, Tockman MS, Swensen SJ, Begg CB. Computed tomography screening and lung cancer outcomes. JAMA 2007; 297: 953–961.
